Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells
about
Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyThe use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigenPriming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCGStable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsHIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in MiceRobust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.E. coli Heat-labile Enterotoxin B Subunit as a Platform for the Delivery of HIV Gag p24 Antigen.Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting MemoryPPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2.Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG.Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model
P2860
Q26798372-A6E2DD16-6ACC-4B9D-B6FD-D563B377BE32Q33952259-0530283E-A572-4997-8237-048BBA7651ECQ34971570-18B23560-DDD6-40CE-99F3-4F0B58860A6CQ35184235-328B3818-43F0-47EF-B608-909DF3B6D9E8Q35773904-7F520856-D979-4940-AFBF-75E552173A93Q36079913-E22F835A-166E-47C6-9E3B-C4376D82BEF2Q36759963-55463E78-B5DB-4221-8432-B20324DEC95AQ37058225-6151AECE-5A7D-46E9-8AA4-AD3786AE94A1Q37563616-C640FF30-1C1B-4B31-B25C-55653CC45F8EQ38207991-C313780E-448C-4B70-BF48-71F6E7378482Q38920325-C71ED1BC-4BE1-4FBA-9FB8-C85081C624CFQ39202380-4748242F-2B71-4BAD-AF2F-55CD2908EEB4Q42213007-EEC0CF27-A0D9-4A90-82A5-12DA0BAE6F8EQ47988525-5FF57CC3-6C51-47BD-8090-A73745D04C56Q56936216-F1E5A039-2D2F-4B93-B7D3-2D1770312895
P2860
Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@ast
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@en
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@nl
type
label
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@ast
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@en
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@nl
prefLabel
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@ast
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@en
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@nl
P2093
P2860
P50
P3181
P1433
P1476
Priming with a recombinant pan ...... IV-1 Gag specific CD8+ T cells
@en
P2093
Irene Garcia
Nicola Douglass
Vasan Sambandamurthy
William Jacobs
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0032769
P407
P577
2012-01-01T00:00:00Z